RPL32P3 and metastatic prostate carcinoma: A total of 163 transcripts comprising 161 genes, a pseudogene (RPL32P3), and an oncogenic lncRNA (MALAT1) were found to be significantly elevated in patients with metastatic prostate cancer compared with localized cases (Fig. 1A; Supplementary Table S2).